Consensus recommendations for the diagnosis and treatment of multiple sclerosis: 2019 revisions to the MENACTRIMS guidelines

B Yamout, M Sahraian, S Bohlega, M Al-Jumah… - Multiple sclerosis and …, 2020 - Elsevier
With evolving diagnostic criteria and the advent of new oral and parenteral therapies for MS,
most current diagnostic and treatment algorithms need revision and updating. The diagnosis …

Diagnosis and treatment of multiple sclerosis: a review

MP McGinley, CH Goldschmidt, AD Rae-Grant - Jama, 2021 - jamanetwork.com
Importance Multiple sclerosis (MS) is an autoimmune-mediated neurodegenerative disease
of the central nervous system characterized by inflammatory demyelination with axonal …

Treatment with disease‐modifying drugs for people with a first clinical attack suggestive of multiple sclerosis

G Filippini, C Del Giovane, M Clerico… - Cochrane database …, 2017 - cochranelibrary.com
Background The treatment of multiple sclerosis has changed over the last 20 years. The
advent of disease‐modifying drugs in the mid‐1990s heralded a period of rapid progress in …

Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and …

A Rae-Grant, GS Day, RA Marrie, A Rabinstein… - Neurology, 2018 - AAN Enterprises
Objective To review evidence on starting, switching, and stopping disease-modifying
therapies (DMTs) for multiple sclerosis (MS) in clinically isolated syndrome (CIS), relapsing …

The importance of early diagnosis of multiple sclerosis.

JR Miller - Journal of managed care pharmacy: JMCP, 2004 - europepmc.org
Objective To describe the current understanding of the diagnosis and treatment of multiple
sclerosis (MS) and to explore the use of magnetic resonance imaging (MRI) assessment as …

Diagnosis and management of secondary-progressive multiple sclerosis: time for change

J Oh, K Alikhani, T Bruno, V Devonshire… - Neurodegenerative …, 2019 - Taylor & Francis
Identifying the transition of relapsing-remitting multiple sclerosis (MS) to the secondary-
progressive MS form remains a clinical challenge due to the gradual nature of the transition …

Diagnosis and differential diagnosis of multiple sclerosis

IBK Sand, FD Lublin - CONTINUUM: Lifelong Learning in …, 2013 - journals.lww.com
Abstract Purpose of Review When a patient presents with symptoms or imaging suggestive
of multiple sclerosis (MS), making the correct diagnosis may at times be straightforward but …

The MSBase registry: informing clinical practice

T Kalincik, H Butzkueven - Multiple Sclerosis Journal, 2019 - journals.sagepub.com
Over the last decade, clinical registries have significantly contributed to the pool of evidence
that supports management decisions in patients with multiple sclerosis. Being the largest …

[HTML][HTML] Multiple sclerosis, a treatable disease

A Doshi, J Chataway - Clinical Medicine, 2017 - Elsevier
This article reviews our current understanding and modern treatment of multiple sclerosis
(MS). MS is a disabling condition resulting in devastating social and economic impacts. As …

Symptomatic treatment and management of multiple sclerosis

A Toosy, O Ciccarelli, A Thompson - Handbook of clinical neurology, 2014 - Elsevier
The range of symptoms which occur in multiple sclerosis (MS) can have disabling functional
consequences for patients and lead to significant reductions in their quality of life. MS …